Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (21-30 of 655) with videos related to

Pageof 66
Sort By:
Clinical Pharmacology and Therapeutics|January 20, 2009
The price of success: cost-effectiveness of molecularly targeted agentsS Sleijfer, J Verweij
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Several patients with a metastasised gastrointestinal stroma-cell tumor for whom the tide turned by the introduction of imatinib]H Gelderblom, J Verweij
Seminars in Oncology|March 12, 1999
High-dose chemotherapy in adult sarcomas: no standard yetC Seynaeve, J Verweij
Critical Reviews in Oncology/Hematology|May 9, 2000
Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study designF A Eskens, J Verweij
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1986
The treatment of soft tissue sarcomas with focus on chemotherapy: a reviewH M Pinedo, J Verweij
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Mitomycin CJ Verweij, H M Pinedo
Cancer Treatment and Research|January 1, 1997
Adjuvant chemotherapy of soft tissue sarcomasJ Verweij, H M Pinedo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Topoisomerase I inhibition: a new target or new missiles?J Verweij, J H Schellens
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Mitomycin CJ Verweij, H M Pinedo
Seminars in Oncology|January 13, 1998
Review of phase I clinical studies with topotecanE K Rowinsky, J Verweij
Pageof 66

Showing results (21-30 of 655) with videos related to

Sort By:
Pageof 66
Clinical Pharmacology and Therapeutics|January 20, 2009
The price of success: cost-effectiveness of molecularly targeted agentsS Sleijfer, J Verweij
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Several patients with a metastasised gastrointestinal stroma-cell tumor for whom the tide turned by the introduction of imatinib]H Gelderblom, J Verweij
Seminars in Oncology|March 12, 1999
High-dose chemotherapy in adult sarcomas: no standard yetC Seynaeve, J Verweij
Critical Reviews in Oncology/Hematology|May 9, 2000
Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study designF A Eskens, J Verweij
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1986
The treatment of soft tissue sarcomas with focus on chemotherapy: a reviewH M Pinedo, J Verweij
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Mitomycin CJ Verweij, H M Pinedo
Cancer Treatment and Research|January 1, 1997
Adjuvant chemotherapy of soft tissue sarcomasJ Verweij, H M Pinedo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Topoisomerase I inhibition: a new target or new missiles?J Verweij, J H Schellens
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Mitomycin CJ Verweij, H M Pinedo
Seminars in Oncology|January 13, 1998
Review of phase I clinical studies with topotecanE K Rowinsky, J Verweij
Pageof 66